CEBP-altered B-ALL: Two transcriptomic profiles across the age spectrum

• by Jacqueline A. Rehn, Ashlee J. Thomson-Roberts, David T. Yeung, Deborah L. White, Elyse C. Page

• October 17, 2026

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

• October 15, 2026

• 1 min

Survival Outcomes With Lu-177 PSMA by Treatment Line and Taxane Sequencing in Prostate Cancer

• by Varun Nandakumar, Yeonjung Jo, Micah Ostrowski, Georges Gebrael, Zeynep Irem Ozay, Edwin Lin, Krishnam Goel, Rachel Revillo, Laxmi Upadhyay, Tejita Agarwal, Nicolas Sayegh, Vinay Mathew Thomas, Haoran Li, Neeraj Agarwal, Umang Swami

• October 15, 2026

Author Correction: Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS

• by Yuta Adachi, Ryo Kimura, Kentaro Hirade, Shogo Yanase, Yuki Nishioka, Natsumi Kasuga, Rui Yamaguchi, Hiromichi Ebi

• October 19, 2026